Experience

Emergent BioSolutions

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Director of Engineering, Facilities, Validation

  • Jan 2022 - Present



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Engineering Operations Director

  • Jun 2017 - Dec 2021

  • Leading a team of 70 consisting of process engineering, automation engineering, capital projects, facility maintenance, and engineering compliance supporting 3 value streams across two manufacturing plants for the manufacture of 5 biological assets, including Nucala, Benlysta, and Belantamab • Champion of the sites digital transformation ambition strategy including MES, data acquisition, data analytics, and data visualization

• Proces Engineering Manager

  • Jan 2014 - Jun 2017

  • Lead a Process Engineering team of 15 to support manufacturing, capital projects, compliance, and process improvements supporting 2 value streams for the manufacturer of 2 biological assets.

• Senior Process Engineer

  • Apr 2007 - Jan 2014

  • Managed the commercial launch manufacture of Nucala in the New Product Introductions (NPI) group in 2013 as a development role • Managed $5M in capital projects to implement facility changes for the Nucala (Mepolizumab) and Tanzium (albiglutide) cell culture and microbial asset improvements in 2012. • Managed a feasibility study to expand the microbial capacity in the Upper Merion Biopharm site for albiglutide capacity in 2011. • Managed the Upper Merion Biopharm site upstream… Show more • Managed the commercial launch manufacture of Nucala in the New Product Introductions (NPI) group in 2013 as a development role • Managed $5M in capital projects to implement facility changes for the Nucala (Mepolizumab) and Tanzium (albiglutide) cell culture and microbial asset improvements in 2012. • Managed a feasibility study to expand the microbial capacity in the Upper Merion Biopharm site for albiglutide capacity in 2011. • Managed the Upper Merion Biopharm site upstream areas (including the 2 x 10,000L fermentor module) during the $125M albiglutide project in 2009-2011. • Managed the Upper Merion Biopharm downstream cell culture areas during the $50M green-field construction of the Cell Culture Value Steam in 2005-2007.



Biokinetics

• Biotechnology
• 1 - 100 Employee

• Senior Process Engineer

  • Jan 2000 - Apr 2007

  • Worked with major bio-pharmaceutical companies including Wyeth, Amgen, Centocor, Schering Plough, Merck, and Genetech, supporting equipment design, build, commissioning, qualification and start-up. • Built a solid foundation in biotechnology design, engineering design standards, and construction. • Worked with major bio-pharmaceutical companies including Wyeth, Amgen, Centocor, Schering Plough, Merck, and Genetech, supporting equipment design, build, commissioning, qualification and start-up. • Built a solid foundation in biotechnology design, engineering design standards, and construction.